ReviewTranslational cancer research2025
Pathophysiology and perioperative dystrophy of esophagus cancer: association with malnutrition.
Review in Translational cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Integrated analysis of Morusin inhibiting esophageal cancer via network pharmacology molecular dynamics simulation and in vitro validation.Discover oncology · 2026Article
- Exploring Home Nutrition Management Experiences in Postoperative Esophageal Cancer Patients and Their Caregivers: A Study Utilizing Patient Journey Mapping.Patient preference and adherence · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Esophageal cancer (EC) is the ninth most prevalent cancer and the sixth most common cause of cancer-related deaths worldwide. It is characterized by a high mortality rate, a dismal prognosis, and geographic variations. Up to 80% of EC patients experience malnutrition. As a result, such individuals are among the most nutritionally compromised cancer patients. At the time of diagnosis, patients often experience dysphagia and a loss of body weight, typically exceeding 10%. The available therapeutic options, of which surgical resection is the most prominent treatment option, can also lead to severe malnutrition. Following breakthroughs in perioperative care and surgical procedures, enormous progress has been made in surgical resection in the past decade. Despite these advances, malnutrition remains a significant issue after surgery, leading to a loss of muscle mass, weight loss, and the depletion of vital nutrients due to gastrointestinal problems. Such issues aggravate the functionality of life and increase the risk of tumor recurrence, which have significant effects on the prognosis of EC patients. The current study examined the epidemiology, risk factors, pathophysiology, and perioperative dystrophy of EC, and its association with malnutrition. Our findings may play a significant role in addressing the physical, emotional, and socioeconomic effects of EC on patients by uncovering nutritional persecution, refining therapeutic approaches, and ultimately enhancing the quality of life of those affected by this disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.